These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 18950670)
1. A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Gidudu J; Kohl KS; Halperin S; Hammer SJ; Heath PT; Hennig R; Hoet B; Rothstein E; Schuind A; Varricchio F; Walop W; Vaccine; 2008 Dec; 26(52):6800-13. PubMed ID: 18950670 [TBL] [Abstract][Full Text] [Related]
2. Induration at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Kohl KS; Walop W; Gidudu J; Ball L; Halperin S; Hammer SJ; Heath P; Hennig R; Rothstein E; Schuind A; Varricchio F; Vaccine; 2007 Aug; 25(31):5839-57. PubMed ID: 17553602 [No Abstract] [Full Text] [Related]
3. Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data. Kohl KS; Walop W; Gidudu J; Ball L; Halperin S; Hammer SJ; Heath P; Varricchio F; Rothstein E; Schuind A; Hennig R; Vaccine; 2007 Aug; 25(31):5858-74. PubMed ID: 17548132 [No Abstract] [Full Text] [Related]
4. Abscess at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Kohl KS; Ball L; Gidudu J; Hammer SJ; Halperin S; Heath P; Hennig R; Labadie J; Rothstein E; Schuind A; Varricchio F; Walop W; Vaccine; 2007 Aug; 25(31):5821-38. PubMed ID: 17540485 [No Abstract] [Full Text] [Related]
5. Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Halperin S; Kohl KS; Gidudu J; Ball L; Hammer SJ; Heath P; Hennig R; Labadie J; Rothstein E; Schuind A; Varricchio F; Walop W; Vaccine; 2007 Aug; 25(31):5803-20. PubMed ID: 17548135 [No Abstract] [Full Text] [Related]
6. Inadvertent inoculation as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Wenger P; Oleske JM; Kohl KS; Fisher MC; Brien JH; Graham PL; LaRussa PS; Lipton S; Tierney B; Vaccine; 2007 Aug; 25(31):5754-62. PubMed ID: 17537553 [No Abstract] [Full Text] [Related]
7. Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Rüggeberg JU; Gold MS; Bayas JM; Blum MD; Bonhoeffer J; Friedlander S; de Souza Brito G; Heininger U; Imoukhuede B; Khamesipour A; Erlewyn-Lajeunesse M; Martin S; Mäkelä M; Nell P; Pool V; Simpson N; Vaccine; 2007 Aug; 25(31):5675-84. PubMed ID: 17448577 [No Abstract] [Full Text] [Related]
8. Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Wise RP; Bonhoeffer J; Beeler J; Donato H; Downie P; Matthews D; Pool V; Riise-Bergsaker M; Tapiainen T; Varricchio F; Vaccine; 2007 Aug; 25(31):5717-24. PubMed ID: 17493712 [No Abstract] [Full Text] [Related]
9. Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Jones JF; Kohl KS; Ahmadipour N; Bleijenberg G; Buchwald D; Evengard B; Jason LA; Klimas NG; Lloyd A; McCleary K; Oleske JM; White PD; Vaccine; 2007 Aug; 25(31):5685-96. PubMed ID: 17400340 [No Abstract] [Full Text] [Related]
10. Eczema vaccinatum as an adverse event following exposure to vaccinia virus: case definition & guidelines of data collection, analysis, and presentation of immunization safety data. Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; Trolin I; Norton SA; Neff JM; Vaccine; 2007 Aug; 25(31):5725-34. PubMed ID: 17532547 [No Abstract] [Full Text] [Related]
11. Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Beigel J; Kohl KS; Khuri-Bulos N; Bravo L; Nell P; Marcy SM; Warschaw K; Ong-Lim A; Poerschke G; Weston W; Lindstrom JA; Stoltman G; Maurer T; Vaccine; 2007 Aug; 25(31):5697-706. PubMed ID: 17403561 [No Abstract] [Full Text] [Related]
12. Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Tapiainen T; Prevots R; Izurieta HS; Abramson J; Bilynsky R; Bonhoeffer J; Bonnet MC; Center K; Galama J; Gillard P; Griot M; Hartmann K; Heininger U; Hudson M; Koller A; Khetsuriani N; Khuri-Bulos N; Marcy SM; Matulionyte R; Schöndorf I; Sejvar J; Steele R; Vaccine; 2007 Aug; 25(31):5793-802. PubMed ID: 17574313 [No Abstract] [Full Text] [Related]
13. Robust take following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data. Graham PL; LaRussa PS; Kohl KS; Vaccine; 2007 Aug; 25(31):5763-70. PubMed ID: 17537551 [No Abstract] [Full Text] [Related]
14. Progressive vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data. Nell P; Kohl KS; Graham PL; LaRussa PS; Marcy SM; Fulginiti VA; Martin B; McMahon A; Norton SA; Trolin I; Vaccine; 2007 Aug; 25(31):5735-44. PubMed ID: 17540484 [No Abstract] [Full Text] [Related]
15. Generalized vaccinia as an adverse event following exposure to vaccinia virus: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Beigel J; Kohl KS; Brinley F; Graham PL; Khuri-Bulos N; LaRussa PS; Nell P; Norton S; Stoltman G; Tebaa A; Warschaw K; Vaccine; 2007 Aug; 25(31):5745-53. PubMed ID: 17537552 [No Abstract] [Full Text] [Related]
16. Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Jorch G; Tapiainen T; Bonhoeffer J; Fischer TK; Heininger U; Hoet B; Kohl KS; Lewis EM; Meyer C; Nelson T; Sandbu S; Schlaud M; Schwartz A; Varricchio F; Wise RP; Vaccine; 2007 Aug; 25(31):5707-16. PubMed ID: 17408816 [No Abstract] [Full Text] [Related]
17. Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study. Gold MS; Gidudu J; Erlewyn-Lajeunesse M; Law B; Vaccine; 2010 Jun; 28(28):4487-98. PubMed ID: 20434547 [TBL] [Abstract][Full Text] [Related]
18. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Rothstein E; Kohl KS; Ball L; Halperin SA; Halsey N; Hammer SJ; Heath PT; Hennig R; Kleppinger C; Labadie J; Varricchio F; Vermeer P; Walop W; Vaccine; 2004 Jan; 22(5-6):575-85. PubMed ID: 14741147 [No Abstract] [Full Text] [Related]
19. Immunization site pain: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Gidudu JF; Walco GA; Taddio A; Zempsky WT; Halperin SA; Calugar A; Gibbs NA; Hennig R; Jovancevic M; Netterlid E; O'Connor T; Oleske JM; Varricchio F; Tsai TF; Seifert H; Schuind AE; Vaccine; 2012 Jun; 30(30):4558-77. PubMed ID: 22521267 [No Abstract] [Full Text] [Related]
20. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Sejvar JJ; Kohl KS; Bilynsky R; Blumberg D; Cvetkovich T; Galama J; Gidudu J; Katikaneni L; Khuri-Bulos N; Oleske J; Tapiainen T; Wiznitzer M; Vaccine; 2007 Aug; 25(31):5771-92. PubMed ID: 17570566 [No Abstract] [Full Text] [Related] [Next] [New Search]